SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-028733
Filing Date
2021-11-15
Accepted
2021-11-15 17:08:12
Documents
64
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm   iXBRL 10-Q 1182982
2 ex31-1.htm EX-31.1 19283
3 ex31-2.htm EX-31.2 19327
4 ex32-1.htm EX-32.1 8187
  Complete submission text file 0001493152-21-028733.txt   6642852

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE brtx-20210930.xsd EX-101.SCH 51500
6 XBRL CALCULATION FILE brtx-20210930_cal.xml EX-101.CAL 53363
7 XBRL DEFINITION FILE brtx-20210930_def.xml EX-101.DEF 261867
8 XBRL LABEL FILE brtx-20210930_lab.xml EX-101.LAB 444397
9 XBRL PRESENTATION FILE brtx-20210930_pre.xml EX-101.PRE 354471
10 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 1099241
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

IRS No.: 911835664 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37603 | Film No.: 211412243
SIC: 8090 Services-Misc Health & Allied Services, NEC